Delivery Order SPE2DB22D1002-SPE2DB25FLHB7
- Not listed
- The U.S. Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Metformin HCL ER 500 mg tablets in quantities of 1,000 units, with a ceiling value of $1,190.00. This competitively awarded, firm fixed-price delivery order will be fulfilled at the contractor's Conshohocken, Pennsylvania location and is scheduled for completion by July 31, 2025. The contract carries no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Metformin HCL ER 500 mg tablets (1,000 count) under a firm fixed price contract valued at $1,793.20. The award was made on August 12, 2025, with an ultimate completion date of August 13, 2025, and represents a competitively awarded, non-set-aside procurement. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates...
- The Defense Logistics Agency awarded a delivery order valued at $4,513.21 to AmerisourceBergen Drug Corp for the supply of Metformin HCL ER 500 mg tablets in quantities of 1,000 units. This contract represents a firm fixed-price delivery order with an ultimate completion date of August 29, 2025, issued one day prior on August 28, 2025. The award was made on a competitive basis with no set-aside designation. Performance will be executed from AmerisourceBergen's corporate office location in...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Metformin ER 500mg tablets (90-count supply) valued at $1,425.60 under a firm fixed-price contract. This competitively awarded, non-set-aside delivery order was issued on September 2, 2025, with an ultimate completion date of the same day, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Metformin is a first-line diabetes...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,825.69 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 4,564,179,958 tablets of Metformin HCl ER 500 mg. This delivery order was issued under an existing indefinite delivery contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA. The IDC serves as the primary contract vehicle for AmerisourceBergen to deliver...
- The Defense Logistics Agency (DLA) awarded a $1,102.08 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Metformin HCL 500 mg tablets (1000-count units). This non-set-aside contract was awarded on August 22, 2025, with an ultimate completion date of August 25, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,102.08 to AmerisourceBergen Drug Corp for the supply of Metformin HCL 500 mg tablets in quantities of 1,000 units. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award through open procurement. Performance is scheduled for completion by August 21, 2025, with the product to be delivered to the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $48,000 to Amerisourcebergen Drug Corp for the supply of 4562163636 metformin HCL ER 500 mg tablets. As the prime contractor, Amerisourcebergen Drug Corp will deliver 360 units of the specified pharmaceutical product. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania under a period of performance from September 13-14, 2023. The ordering agency, DLA, manages the procurement of...
- The Defense Logistics Agency (DLA) awarded a $1,405.44 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, for the supply of 4,564,416,322 METFORMIN HCL ER 500 MG TABLET 1000S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 held by Amerisourcebergen with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a delivery order valued at $272.06 to provide 4562251449 metformin HCL ER 500 mg tablets (360 count) under a firm fixed price contract. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of one day from September 20th through September 21st, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for metformin tablets...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB25FLHB7Delivery Order
The Defense Logistics Agency awarded a $1,250.16 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Metformin HCL ER 500 mg tablets (180-count units). This competitively awarded, firm fixed-price contract is classified as a child award under a larger indefinite delivery contract vehicle and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with a completion deadline of September 3, 2025. The contract represents a routine pharmaceutical procurement supporting federal medical supply chain requirements. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and established federal healthcare vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical supplies to support military and veteran healthcare systems. The company's contract portfolio with the Defense Logistics Agency demonstrates its capacity to fulfill federal pharmaceutical procurement needs across multiple therapeutic domains, with individual delivery orders ranging substantially in value to support the Defense Health Agency and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/2/25 |